Blavatnik Institute RSS Feed

In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School have identified a new molecular brake that hinders the ability of T cells to attack tumors. The research, published Aug. 12 in Nature Immunology and supported in part by federal funding , offers a new pathway to design treatments that help more patients — a welcome development given that current cancer immunotherapies work in less than half of those who receive them. Get more HMS news The research, done in mice and in human cells, shows that a protein called STUB1…

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the brain never go on to develop dementia? These questions have bedeviled neuroscientists for decades. Now, a team of…